Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Jinying ZhangYongqian Shu

Abstract

Cytokine-induced killer (CIK) cells have the ability to kill tumor cells in vitro and in vivo. This study aimed to evaluate the clinical effect of adjuvant immunotherapy with CIK cells on the prognosis of lung cancer patients. In the present study, we investigated the clinical outcomes of autologous CIK cell immunotherapy for patients with lung cancer in a case-control study. Our study included 60 patients who received chemotherapy combined with autologous CIK cell adoptive immunotherapy in CIK treatment group and 60 patients who received chemotherapy alone in the control group. Progression-free survival (PFS) and overall survival (OS) of these two groups were evaluated. After 14 days of incubation in vitro, the percentages of CD3(+), CD3(+)CD8(+), CD3(+)CD56(+) and CD3(-)CD56(+) were significantly increased (P<0.05). The clinical symptoms of 60 patients were apparently improved. No severe toxicity and side effects were observed in the CIK treatment group. The 3-year, 5-year PFS rates were 44.7% and 26.8% and the 3-year, 5-year OS rates were 74% and 62% in the CIK group, respectively, which were significantly improved compared to that in the control group. The median PFS and OS in the CIK group were significantly improved than ...Continue Reading

References

Jul 1, 1994·British Journal of Haematology·I G Schmidt-WolfR S Negrin
Apr 12, 2002·International Journal of Cancer. Journal International Du Cancer·Constantin N BaxevanisMichael Papamichail
Jan 23, 2004·The New England Journal of Medicine·Alexander Spira, David S Ettinger
May 7, 2004·The New England Journal of Medicine·Brian C Jacobson
Nov 24, 2004·Seminars in Radiation Oncology·Shannon K Penland, Mark A Socinski
May 5, 2005·Cancer Biotherapy & Radiopharmaceuticals·Shu SunWan-Shan Yang
Jun 11, 2005·World Journal of Gastroenterology : WJG·You-Shun ZhangZong-Qing Dai
Jul 23, 2005·Biotechnology and Bioengineering·Sanjay PatelJean-Bernard Le Pecq
Dec 20, 2007·Archives of Pharmacal Research·Hwan Mook KimSang-Bae Han
Aug 5, 2008·Clinical Journal of Oncology Nursing·Suzanne Walker
Sep 27, 2008·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Dong HuiKong Da-Lu
Jan 19, 2010·Cytotherapy·David StroncekTraci Heath-Mondoro
Jun 10, 2010·Cancer Immunology, Immunotherapy : CII·Mike W HelmsChristopher H Contag
Apr 2, 2011·Clinical & Developmental Immunology·Yao WangWeidong Han
Jan 26, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Liang LiuXiubao Ren
Mar 7, 2012·Journal of Cancer Research and Clinical Oncology·Jinying ZhangYongqian Shu
Apr 7, 2012·Clinical & Developmental Immunology·Claudia SchlimperIngo G H Schmidt-Wolf
Apr 17, 2012·Expert Opinion on Biological Therapy·Kam M Hui
May 15, 2012·Cancer Immunology, Immunotherapy : CII·Runmei LiHui Li
Sep 6, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Runbo ZhongHua Zhong

❮ Previous
Next ❯

Citations

Oct 21, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hu LuoXiangdong Zhou
Jul 21, 2016·Technology in Cancer Research & Treatment·Hongjin ChuJian Chen
Aug 19, 2017·Cancer Biotherapy & Radiopharmaceuticals·Hao PengShidong Wei
Jun 3, 2020·Journal of Cellular Physiology·Ying Zhang, Ingo G H Schmidt-Wolf
Dec 31, 2017·American Journal of Reproductive Immunology : AJRI·Wenjun WangJianxing He
Jul 22, 2017·Frontiers in Immunology·Xingchun GaoWeilin Jin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.